
PATRYS LIMITED (ASX:PAB) - Ann: PAT-DX1 clinical development update, 77269719, page-78 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum
Published on January 4, 2025
companies that already have good relations with the FDA and that could fund a trial of DX3 in addition to already approved trials to see if
